
Advertise on podcast: Pear Healthcare Playbook
Rating
5from
This podcast has
81 episodes
Language
EnglishPublisher
Pear VCExplicit
No
Date created
2022/01/25
Latest episode
2026/11/12
Average duration
46 min.
Release period
35 days
Description
We share stories from trailblazing entrepreneurs and leaders on how to build a healthcare business from 0 to 1.
Unlock Pear Healthcare Playbook podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Podcast episodes
Check latest episodes from Pear Healthcare Playbook podcast
Lessons from Andrew Lacy, Building Whole-Body MRI to Make Healthcare Proactive Instead of Reactive
2026/11/12
Welcome back to the Pear Healthcare Playbook! Every week, we'll be getting to know trailblazing healthcare leaders and diving into building a digital health and biotech business from 0 to 1.
We would greatly appreciate it if you took a moment to listen to the episode on either Apple or Spotify and leave us a rating! Your support helps our guests' insights reach a larger audience!
Today we're thrilled to share our interview with Andrew Lacy, Founder and CEO of Prenuvo, a whole-body MRI screening company. Prenuvo has screened more than 100,000 people across over 170,000 scans, raised more than $190 million across five funding rounds.
In this conversation, Andrew walks through why MRI is a great imaging modality for whole-body screening, how Prenuvo thinks about pricing and the FSA/HSA system, what its own published research shows and doesn't show, and how the company is navigating a vocal, organized pushback from parts of the radiology establishment while trying to make proactive screening the standard of care instead of just a luxury good.
Teodor Grantcharov on Aimbient: Building the Intelligence Layer for Procedural Care
2026/11/04
Welcome back to the Pear Healthcare Playbook!
Today we’re thrilled to host Dr. Teodor Grantcharov, founder and CEO of Aimbient, formerly known as Surgical Safety Technologies. Aimbient is building the intelligence layer for procedural care, using ambient AI to improve patient safety, clinical outcomes, and operational efficiency. Building on Teodor’s pioneering work developing the OR Black Box, Aimbient has expanded to more than 650 procedural rooms across North America and Europe.
In this episode, we discuss Teodor’s journey from surgeon-scientist to entrepreneur, the challenges of bringing the OR Black Box into hospitals, and how Aimbient is evolving from retrospective surgical analysis to predictive and real-time intelligence across procedural care.
Wyatt McDonnell of Infinimmune on Finding Better Antibodies in the Human Immune System
2026/10/14
Welcome back to the Pear Healthcare Playbook!
Today we’re thrilled to host Wyatt McDonnell, co-founder and CEO of Infinimmune. Founded in 2022, Infinimmune is taking a new approach to antibody drug discovery by using the human immune system as a guide. Their thesis is that some of the best therapeutic antibodies may already exist within people and the company combines large-scale single-cell sequencing of human B cell repertoires with its proprietary discovery platform and antibody language models to identify and engineer human-derived therapeutics. Infinimmune has built an internal pipeline across inflammatory and autoimmune diseases, announced an $838 million multi-target antibody discovery collaboration with Merck, and raised a $75 million Series A as of August 2026.
In this conversation, Wyatt explains how Infinimmune finds promising antibodies in the human immune repertoire and engineers them for therapeutic development. He also explains what it takes to build a durable therapeutics company around a discovery platform.
Vikas Sabnani on Marit Health: Building the Glassdoor for Medicine by Making Healthcare Compensation Transparent
2026/09/02
Welcome back to the Pear Healthcare Playbook! Every week, we'll be getting to know trailblazing healthcare leaders and diving into building a digital health and biotech business from 0 to 1.
We would greatly appreciate it if you took a moment to listen to the episode on either Apple or Spotify and leave us a rating! Your support helps our guests' insights reach a larger audience!
Today we're thrilled to share our interview with Vikas Sabnani, Co-founder and CEO of Marit Health, a free, AI-powered career community platform built for physicians and advanced practice providers. Clinicians share their own compensation data and in exchange get access to tens of thousands of real peer-reported salaries across every specialty and state, including the details that actually matter like base pay, bonuses, call schedules, hours worked, PTO, and benefits. Think of it as a Glassdoor for medicine. Marit also runs an AI powered jobs platform that matches clinicians to roles based on their specific preferences. In just fifteen months since launching, more than 100,000 clinicians have joined, making Marit one of the fastest growing community platforms in medicine [1]. Before Marit, Vikas spent seven years at Glassdoor and then joined Transcarent as head of product. In this conversation, Vikas walks through his path from Glassdoor to healthcare, how Marit's co-founder started the company on a Google Sheet, the anonymization architecture that protects physicians in small specialties, and how the platform is turning transparency into a business.
Arpan, Amit, and Kyle Cofounders of Kin Health on Rebuilding the Health Record Around the Patient
2026/08/25
Welcome back to the Pear Healthcare Playbook! Every week, we'll be getting to know trailblazing healthcare leaders and diving into building a digital health and biotech business from 0 to 1.
We would greatly appreciate it if you took a moment to listen to the episode on either Apple or Spotify and leave us a rating! Your support helps our guests' insights reach a larger audience!
Today we're thrilled to share our interview with Arpan Parikh, MD and Amit Parikh, MD, and Kyle Alwyn, the co-founders of Kin Health, a free app that records patients' doctor visits, turns them into a plain-English summary with next steps, and helps them act on what they were told. Kin closed a $9 million seed round with GoodRx co-founders Doug Hirsch and Trevor Bezdek joining as founding partners and executive chairmen.1 In this conversation, Arpan, Amit, and Kyle walk through the personal and professional catalysts behind Kin, how the company is borrowing (and adapting) the GoodRx playbook, how Kin complies with security and privacy, and how they think about consent in a world where both doctor and patient are now showing up to the visit with their own AI listening in.
Sahir Jaggi on Forus: Building the AI Infrastructure for Medication Access
2026/08/24
Welcome back to the Pear Healthcare Playbook!
Today we’re thrilled to host Sahir Jaggi, founder and CEO of Forus, formerly known as Tandem. Forus is building the infrastructure layer for medication access, helping providers navigate the complex journey from prescription to treatment. The company recently announced that it has raised more than $160 million and now supports thousands of practices across all 50 states.
In this episode, we discuss Sahir’s journey from Oscar Health to founding Forus, why medication access remains so broken, and how Forus grew from individual clinics into a nationwide provider network.
David Lortscher on Curology: Building a Billion-Dollar Prescription Skincare Company
2026/08/12
Today we're thrilled to host David Lortscher, MD, co-founder and board chair of Curology, the personalized prescription skincare company he built out of a telehealth experiment in 2014. Curology has since grown into a business that has served more than 5 million patients. After a decade as CEO, David stepped back into the board chair role in 2022 and has since written Why Doctors Win: The Doctor's Guide to Creating or Joining a High-Impact Startup, based on exclusive interviews with physician founders of ten category-leading healthcare companies. In this conversation, David walks through how he first started the company, raising investor money as a physician, how he built a compounding pharmacy, growing to a 50-state clinician network, and discusses his new book!
Mark Cuban on Breaking the Drug Pricing Cartel: Inside Cost Plus Drugs
2026/07/08
Welcome back to the Pear Healthcare Playbook! Every week, we'll be getting to know trailblazing healthcare leaders and diving into building a digital health and biotech business from 0 to 1.
Today we're thrilled to host Mark Cuban, co-founder of the Mark Cuban Cost Plus Drug Company. Cost Plus launched in 2022 with a simple promise: sell generic drugs at the actual cost plus a transparent 15% markup, no hidden fees, no middlemen. In this conversation, Mark walks through how a cold email turned into a company that's now taking on the entire pharmacy benefit infrastructure of the country, from generics to manufacturing to direct provider contracting.
Lessons from Ron Alfa, Co-Founder and CEO of Noetik, on Bringing AI-Native Precision Oncology to Every Cancer Patient
2026/06/30
Welcome back to the Pear Healthcare Playbook!
Today we’re thrilled to host Ron Alfa, co-founder and CEO of Noetik. Noetik is building an AI-native platform for cancer biology, generating large-scale human data to train biological foundation models that both predict patient responses to therapy and uncover new drug targets and treatment opportunities. Most recently, Noetik signed a $50 million licensing agreement with GSK, giving GSK access to Noetik’s virtual cell foundation models, along with one of the largest multimodal spatial oncology datasets assembled to date.
In this episode, we discuss Ron’s journey to founding Noetik, why building truly useful models of biology requires large-scale, multimodal human data, and how biological foundation models can transform precision oncology. We also explore what it takes to build an AI-native biotech company, lessons from partnering with pharma, the future of drug discovery, and the path toward bringing more personalized cancer treatment to every patient.
Lessons from Anirudh Joshi, Co-Founder and CEO of Valar Labs, on Bringing AI-Native Precision Oncology to Every Cancer Patient
2026/05/12
Welcome back to the Pear Healthcare Playbook! Every week, we’ll be getting to know trailblazing healthcare leaders and diving into building a digital health and biotech business from 0 to 1.
We would greatly appreciate it if you took a moment to listen to the episode on either Apple or Spotify and leave us a rating! Your support helps our guests' insights reach a larger audience!
Today we're thrilled to host Anirudh Joshi, co-founder of Valar Labs, who is building the company with co-founder Viswesh Krishna. Valar is pioneering AI-native oncology diagnostics using standard pathology slides to predict treatment response, starting with bladder cancer and expanding across oncology.
The company raised a $22M Series A co-led by DCVC and Andreessen Horowitz, with continued backing from Pear VC since day one. In this conversation, Anirudh walks through how the genesis of the company, why pathology has long been underutilized and what it took to bring Vesta, its genitourinary-focused portfolio of AI powered pathology tests, to the clinic.
Lessons from Jeffery Liu, Co-Founder and Co-CEO of Assort Health, on Fixing the Front Door of Healthcare with AI Agents
2026/03/10
Welcome back to the Pear Healthcare Playbook!
Today we’re excited to sit down with Jeffery Liu, Co-Founder and Co-CEO of Assort Health, a company building specialty-specific AI voice agents to fix the front door of healthcare. Assort is reimagining patient access by reducing hold times, improving scheduling, and helping patients get to the right care faster.
In this episode, we explore how Assort got started, why patient access has remained such a stubborn problem in healthcare, and what the team learned from shipping its earliest real-world deployments. We dive into why specialty-specific workflows matter, how Assort thinks about encoding the complexity of scheduling and triage, and what it takes to turn highly customized implementations into a scalable platform. We also discuss the company’s broader vision for AI-powered patient navigation across voice, text, and other channels.
Lessons from Othman Laraki, CEO of Color Health, on Removing Friction for Virtual-first, End-to-end Cancer Care
2025/12/01
Welcome back to the Pear Healthcare Playbook!
Today we're thrilled to sit down with Othman Laraki, Co-founder and CEO of Color Health, a company reinventing cancer care through a virtual-first, end-to-end model. Othman has spent his career at the intersection of technology and healthcare—from helping build Chrome at Google to leading product at Twitter to founding Color, where he now focuses on expanding access to high-quality cancer prevention, screening, and treatment.
In this episode, we explore how Color got started, what the team learned transitioning from genomics into full-stack care delivery, and why reducing friction across the care pathway is critical for improving outcomes. We dive into how Color’s model works across the entire cancer journey, how the company thinks about system-level change and distribution, and how AI—through collaborations with OpenAI and Google Cloud—is powering new capabilities for patients and clinicians.
Lessons from Travis Zack, CMO of OpenEvidence, on Making Clinical Evidence Instantly Accessible through AI
2025/10/27
Today we're thrilled to get to know Travis Zack, Chief Medical Officer of OpenEvidence. OpenEvidence is the world's leading medical information platform and the fastest growing applications for physicians in history. Over 40% of US clinicians leverage OpenEvidence for evidence based practice support that is directly embedded into their workflows.
Through an array of strategic content partnerships (including the American Medical Association, The New England Journal of Medicine, The Journal of the American Medical Association, and all eleven JAMA specialty journals—such as JAMA Oncology and JAMA Neurology) OpenEvidence gives clinicians the power to search once, skip the scavenger hunt, and surface the science in seconds. Most recently, OpenEvidence has raised $200M in its Series C from Top Investors like Sequoia, GV Thrive, Kleiner Perkins and others!
In this episode, we discuss how OpenEvidence is transforming access to medical evidence, the company’s rapid growth and adoption by clinicians, its business model and journal partnerships, and the future roadmap for AI-powered clinical decision support.
Lessons from Amar Kendale, Cofounder and President of Homeward, on Addressing Care Gaps in Rural Health
2025/08/04
Welcome back to the Pear Healthcare Playbook! Every week, we’ll be getting to know trailblazing healthcare leaders and diving into building a digital health business from 0 to 1.
We would greatly appreciate if you took a moment to listen to the episode on either Apple or Spotify and leave us a rating! Your support helps our guests' insights reach a larger audience!
Today we're grateful to get to know Amar Kendale, Co-founder and President of Homeward, a company reinventing how care is delivered in rural America. Amar has spent the last 20 years building healthcare products that make life better for patients, providers, and health plans. At Homeward he is focused on improving access to care in rural communities. Before that, he helped grow Livongo from an early-stage startup to its $18B acquisition by Teladoc, where he became Chief Product Officer.
In this episode, we’re diving into how Homeward started, the challenges in building in rural health, how Homeward operates and gets paid, and how the company hopes to scale and navigate the upcoming year.
Adam Stansell, CEO and Founder of Axle Health, bringing operational excellence to home health
2025/07/16
Today, we’re excited to get to know Adam Stansell, CEO and Founder of Axle Health, the operating system for Home Health.
Before founding Axle, Adam spearheaded the launch of new markets at UberEats and built a high-growth business line at Motive, a leader in fleet logistics. With deep expertise at the intersection of operations, technology, and scale, he’s now bringing world class logistics to one of healthcare’s most overlooked frontiers: home health.
Founded in 2020, Axle is tackling the $150B+ home health industry in the US growing at 9% every year, of which most of home health still runs on old legacy software or spreadsheets. Recently announced, Axle has raised $10M in Series A led by Carl Byers and Julia McDowell at F-Prime Capital, joined by Lightbank and previous investors YC and us at Pear VC! We at Pear, especially my GP Mar Hershenson and I have been super grateful to be part of his journey.
Podcast reviews
Read Pear Healthcare Playbook podcast reviews
nprisdumb 2026/10/31
Informative on healthcare
Great podcast must listen!
AP_LA 2026/09/22
A must listen
One of my favorite healthcare and health tech podcasts!
Hamzah yus 2026/09/16
Phenomenal podcast
Such an engaging podcast. Unmatched guest caliber and a great listen for anyone interested in health tech
VA4848 2026/07/12
Great posdcast
This is an excellent podcast! I got some wonderful insight on healthcare topics and issues.
CG1939 2026/06/21
Awesome listen
Great show and insightful lessons on healthcare
Yik9990 2026/02/08
Great Listener Experience
The host does a great job in his preparation and this results in great content. Typically, I get a good overview of the guest’s background and enough ...
cr_57 2026/01/28
Great Podcast!
Listened to the CMO of OpenEvidence hosted by Andrew. Great host, great topics of discussion, overall solid podcast.
Vex1019 2025/12/18
Ultra Insightful Podcast
As someone who has contributed to a successful podcast in years prior, the work of Pear VC in Pear Healthcare Playbook is just phenomenal. Anyone inte...
PulledByStars 2025/12/16
Valuable insights
I highly recommend this podcast to all founders in healthtech space.
PaxosHMK 2025/11/24
Excellent guests and awesome hosts
This is such a great podcast! Learn so much from every episode, and as a healthcare founder there are tons of insights I’m incorporating into our stra...
Podcast sponsorship advertising
Start advertising on Pear Healthcare Playbook relevant audience podcasts
You may also like to advertise on these Podcasts

4.959962000
Legal AF by MeidasTouch
MeidasTouch Network

4.7292842000
The Michael Knowles Show
The Daily Wire

4.897081456
The Graham Allen Show
Graham Allen

4.930902000
The Quote of the Day Show | Daily Motivational Talks
Sean Croxton

4.7106622000
FantasyPros - Fantasy Football Podcast
iHeartPodcasts

4.6253972000
The Glenn Beck Program
Mercury Radio Arts

4.8224901808
The Andrew Klavan Show
The Daily Wire

4.6652782197
The Charlie Kirk Show
Charlie Kirk

4.8259411508
Relatable with Allie Beth Stuckey
Blaze Podcast Network

4.818422000
The Cabral Concept
Dr. Stephen Cabral